|
2010
|
Wacht Nathalie

|
Thema: Novel substances for high risk CLL patients „CLL1“ – a promising option
|
|
2010
|
Asslaber Daniela

|
Thema: MicroRNAs in the Pathology of B-Cell Chronic Lymphocytic Leukemia
|
|
2010
|
Olivier Angelika
|
Thema: The Chemokine Network: CCL27/ CTACK in Multiple Myeloma and Implications in Immune Cell Function“
|
|
2010
|
Maizner Eva
|
Thema: Expression profiles of PKB/AKT isoforms in multiple myeloma
|
|
2009
|
Hofbauer Sebastian

|
Thema: The Role of Protein Kinase B and Tcl1a in the Survival of B – Chronic Lymphocytic Leukemia Cells
|
|
2009
|
Desch Petra

|
Thema: Cancer Stem Cells and Self-Renewal Pathways in B-Cell Chronic Lymphocytic Leukemia
|
|
2008
|
Gryshchenko Irina

|
Thema: Rolle des SNP309 im Promotor von MDM2 und p53 Status bei chronisch lymphatische Leukämie (B-CLL)
|
|
2008
|
Holler Claudia

|
Thema: The Role of T cell receptor and B cell receptor characteristics in B cell chronic lymphocytic leukaemia (CLL)
|
|
2008
|
Melchardt Thomas

|
Thema: New Drugs for high risk B-CLL patients: Screening of plant and microbe derived compounds
|
|
2004
|
Anedter Gabriele
|
Thema: Apoptotische und antiapoptotische Signale und deren medikamentösen Beeinflussung der B-Zell chronisch lymphatischen Leukämie
|